Answers are grounded in this paper and cite their sources.
Ferroptosis, an iron‐dependent form of regulated cell death, is increasingly recognized as a key driver of renal tubular injury and kidney disease progression. Here, screening a focused library of nitrogen‐containing heterocycles identifies benzo[ d ]imidazo[1,2‐ a ]imidazoles as a selective ferroptosis‐inhibitory chemotype, with little or no protection against apoptosis, necrosis, cuproptosis, parthanatos, necroptosis, or pyroptosis. Structure–activity relationship analysis of 40 derivatives yields X27 , which inhibits RSL3‐induced ferroptosis in HT‐1080 and renal tubular epithelial HK‐2 cells with EC 50 values of 0.13 and 0.19 µ M , respectively, without detectable radical‐scavenging or iron‐chelating activity. Mechanistically, X27 binds the NCoA4 383–522 fragment with a K D of 0.28 µ M , suppresses ferritin degradation and labile iron accumulation, and attenuates lipid peroxidation. An activity‐retaining photoaffinity probe, X31 , enriches endogenous nuclear receptor coactivator 4 (NCoA4), while LC–MS/MS localizes probe modification to a peptide spanning Asp440–Lys452, defining a putative small‐molecule interaction region. In mice, X27 attenuates cisplatin‐induced acute kidney injury and unilateral ureteral obstruction‐induced renal injury and fibrosis. Together, these findings expand the chemical space of NCoA4 ligands, provide peptide‐level insight into small‐molecule recognition by NCoA4, and establish ferritinophagic iron mobilization as a chemically tractable node for controlling renal injury.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: